A CLINICAL TRIAL TO STUDY THE EFFICACY OF HOMOEOPATHIC MEDICINE IN PREVENTION AND CURE OF CORONA VIRUS DISEASE 19
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/05/025049
- Lead Sponsor
- SAI NIDAN HOMOEOPATHY CLINIC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
MALES OR FEMALES WITH A DIAGNOSIS OF COVID 19 AND MALES OR FEMALES QUARANTINE PERSON FOR COVID 19
Exclusion Criteria
NI
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary endpoint of this trial will be measured in terms of clinically recovered cases (covid 19 negative)or deathTimepoint: 1 MONTH
- Secondary Outcome Measures
Name Time Method Improvement in the quality of life w.r.t. activity, appetite , sleep and general condition of patient. fever clearance , changes in severity of symptoms, resolution of pneumoniaTimepoint: every 7 days;Suspected cases in quarantine confirmed as negativeTimepoint: 14 days